Supporting evidences for potential biomarkers of endometriosis detected in peripheral blood  by Signorile, Pietro G. & Baldi, Alfonso
Contents lists available at ScienceDirect
Data in Brief








E-mjournal homepage: www.elsevier.com/locate/dibData ArticleSupporting evidences for potential biomarkers
of endometriosis detected in peripheral blood$Pietro G. Signorile n, Alfonso Baldi n
Fondazione Italiana Endometriosi, Rome, Italya r t i c l e i n f o
Article history:
Received 27 September 2015
Received in revised form
24 October 2015
Accepted 29 October 2015
Available online 17 November 2015x.doi.org/10.1016/j.dib.2015.10.047
09/& 2015 The Authors. Published by Else
reativecommons.org/licenses/by/4.0/).
ore details, please refer to [1].
esponding authors.
ail addresses: research@endometriosi.it (P.Ga b s t r a c t
Incidence of endometriosis is very high in women in the reproductive
age (around 10%). To date, a reliable non-invasive diagnostic test for
early diagnosis of endometriosis is not available. In this article we
describe the potential value as diagnostic markers for endometriosis of
two proteins (serum albumin and complement C3 precursor), pre-
viously identiﬁed as differentially expressed in women with endo-
metriosis respect to healthy control by 2D gel analysis. A detailed
description of the results obtained with this proteomic approach can
be found in Signorile and Baldi [1]. ELISAs were performed on a large
cohort of endometriosis (n¼100) and healthy patients (n¼10) to
establish the differential expression of the identiﬁed proteins. ROC
analyses conﬁrmed the statistical signiﬁcance of the differential
expression of these proteins: serum albumin (p¼0.028) ad comple-
ment C3 precursor (p¼0.082). Evaluation of these two proteins,
together with the already described Zn-alpha2-glycoprotein [1], could
help in the early identiﬁcation of endometriosis patients
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Value of the data
 Deﬁnition of the expression of serum albumin and C3 complement could help identify patients
suffering for endometriosis at an early stage.
 Assessment of the expression of the two proteins in the serum by ELISA make this analysis easily
reproducible.
 Deﬁnition of the experimental condition to detect these two proteins, together with the already
described Zn-alpha2-glycoprotein [1], represents the rational basis for simultaneously analysis of
these potential biomarkers in a wide cohort of endometriosis patients.1. Data
Endometriosis is one of the most common gynecological diseases in women during the repro-
ductive age [2,3]. Despite of this, endometriosis is one of the human diseases where a very long time-
interval exists between insurgence of the symptoms and ﬁnal diagnosis, making it one of the most
under-diagnosed and under-treated disease [4–7]. Therefore, the clinical value of a non-invasive
diagnostic test for endometriosis would be enormous, because it could allow to immediately identify
among women with sub-fertility, those suffering of endometriosis and to rapidly perform laparo-
scopic surgery, that has been reported to increase fertility [8,9]. ELISA tests were performed on a
cohort of endometriosis (n¼100) and healthy patients (n¼10) in order to conﬁrm the differential
expression of two proteins, complement C3 and human albumin identiﬁed through the proteomic
approach described in Signorile and Baldi [1]. Interestingly, most of the albumin was depleted before
performing the 2D gel analysis. However, albumin was still identiﬁed among the differential
expressed markers as it is stated in Table 3 of the original paper [1]. ROC analysis of ELISA results
conﬁrmed the statistical signiﬁcance of the differential expression for these proteins in endometriosis
patients respect to healthy controls. In Fig. 1, the ROC curves for these proteins are depicted, together
with speciﬁcity and sensitivity.2. Experimental design, materials and methods
2.1. Sample collection and serum preparation
Details about the recruitment of the human subjects can be found in Signorile and Baldi [1].
Brieﬂy, the control group included 10 healthy women in reproductive age, with no clear signs of
endometriosis, such as irregular cycling and ovulating, and that had at least one normal pregnancy.
The group of endometriosis patients included only subjects where the diagnosis of endometriosis was
deﬁnitively conﬁrmed by laparoscopy and histology. Exclusion criteria in the group of endometriosis
patients were: a) patients using hormonal medication; b) patients operated within 6 months before
the time of sample collections and c) patients suffering of degenerative, autoimmune or neoplastic
diseases. The clinical characteristics of the patients enrolled are described in Signorile and Baldi [1].
Analysis was done on a subset of the patient enrolled in the previous paper. A speciﬁc selection of the
Fig. 1. ROC curves for (A) human serum albumin and (B) complement C3, together with speciﬁcity and sensitivity.
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milliliters of peripheral blood were obtained from patients by venipuncture, collected in EDTA tubes
and stored at þ4 °C. In order to collect sera, samples were centrifuged at 3000 rpm for 10 min at 4 °C,
aliquoted in sterilized tubes, labeled and stored at 80°C. Samples that were haemolysed during the
procedure, were not included in the study protocol.2.2. Enzyme-linked immunosorbent assay (Elisa)
Elisa tests were performed using the dedicated Abnova kits for human serum albumin (Catalogue
KA0455) and Complement C3 (Catalogue KA1020), following the manufacturer's protocols.2.3. Statistical analysis
Receiver operating characteristics (ROC) curve analyses were performed to determine the best
predictor of endometriosis between the tested variables. Statistical analysis was performed with the
SPSS package (version 13.05, SPSS, Inc.).Conﬂict of interest
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